Results

eNauka >  Results >  Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial
Title: Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial
Authors: Rosenstock, Julio; Emral, Rifat; Sauque-Reyna, Leobardo; Mohan, Viswanathan; Trescoli, Carlos; Al Sifri, Saud; Lalić, Nebojša  ; Alvarez, Agustina; Picard, Pascaline; Bonnemaire, Mireille;
Demil, Nacima; McCrimmon, Rory J;
Issue Date: 2021
Publication: Diabetes Care
ISSN: 0149-5992 Diabetes Care Search Idenfier
Publisher: Alexandria Va : American Diabetes Association
Type: Article
Collation: vol. 44 br. 10 str. 2361-2370
DOI: 10.2337/dc21-0393
WoS-ID: 000743313800029
Scopus-ID: 2-s2.0-85114762701
PMID: 34183429
PMCID: PMC8740944
URI: https://enauka.gov.rs/handle/123456789/801035
URL: https://diabetesjournals.org/care/article/44/10/2361/138541/Advancing-Therapy-in-Suboptimally-Controlled-Basal
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

42
SCOPUSTM
18
PubMed CentralTM
11
OpenCitations
36
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.